Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing

Frontiers in Cell and Developmental Biology
Sanjeev Kumar GuptaKeyur P Patel

Abstract

Somatic hypermutation (SHM) status provides an important prognostic indicator for chronic lymphocytic leukemia (CLL), a very common type of mature B-cell leukemia. Owing to the adverse prognosis associated with an unmutated immunoglobulin heavy chain variable (IGHV) status, SHM testing is performed as a standard of care in CLL. Conventionally, SHM testing has been performed using labor intensive and primarily analog Sanger sequencing method following PCR amplification of the clonal immunoglobulin heavy chain gene rearrangements in CLL cells. In comparison, recent availability of next generation sequencing (NGS) allows more versatile detection and direct identification of clonal immunoglobulin gene rearrangements in neoplastic B-cell populations. The ability to identify specific clonal IGHV signature(s) in both baseline (diagnostic) and post-treatment settings enables unique clinical applications of NGS such as determination of SHM status, minimal residual disease (MRD) monitoring, clonal heterogeneity and B cell receptor IG stereotypy. We provide a review of current practices and recommendations for SHM determination using NGS including examples of difficult cases.

References

Dec 5, 1991·Journal of Molecular Biology·J D MarksG Winter
Apr 14, 1983·Nature·S Tonegawa
Apr 1, 1995·Current Opinion in Immunology·M S Neuberger, C Milstein
Oct 28, 1998·The Journal of Clinical Investigation·F FaisN Chiorazzi
Dec 15, 2006·Leukemia·P GhiaUNKNOWN European Research Initiative on CLL
Mar 3, 2007·Annual Review of Biochemistry·Javier M Di Noia, Michael S Neuberger
Dec 14, 2011·Proceedings of the National Academy of Sciences of the United States of America·Aaron C LoganDavid B Miklos
May 15, 2013·Nucleic Acids Research·Jian YeJames M Ostell
Oct 22, 2013·Current Opinion in Immunology·Harlan Robins
Nov 8, 2014·Nucleic Acids Research·Marie-Paule LefrancSofia Kossida
Jan 31, 2015·Blood·Panagiotis BaliakasKostas Stamatopoulos
Mar 20, 2015·Proceedings of the National Academy of Sciences of the United States of America·James S BlachlyJohn C Byrd
Nov 5, 2016·Leukemia·K StamatopoulosP Ghia
Nov 16, 2016·Haematologica·Dörte WrenUNKNOWN EuroClonality-NGS consortium
Apr 19, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hanna IJspeertMirjam van der Burg
Mar 28, 2019·Frontiers in Immunology·Bas Pilzecker, Heinz Jacobs

❮ Previous
Next ❯

Citations

Jul 23, 2021·The Journal of Molecular Diagnostics : JMD·Caleb Ho, Paul G Rothberg
Sep 5, 2021·Scientific Reports·Crescenzio Francesco MinerviniFrancesco Albano

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
electrophoresis
chip
Assay
RNA-seq
flow cytometry

Software Mentioned

IMGT
JunctionAnalysis
Integrated Genome Viewer ( IGV
MySQL
QUEST
IMEX
IgBlast
Invivoscribe
ARGalaxy
Lymphotrack

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.